Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality

Author:

Maass Katie F.1ORCID,Barfield Matthew D.2,Ito Mototsugu3,James Christopher A.4ORCID,Kavetska Olga5,Kozinn Marc6,Kumar Parag7,Lepak Maureen8,Leuthold Luc Alexis9,Li Wenkui9,Mikhailov Dmitri9,Patel Shefali10ORCID,Perez Nisha L.1112,Jackson Rudd Deanne13,Vakkalagadda Blisse6ORCID,Williams Tracy M.14,Zha Jiuhong15,Zhang Xin14,Anderson Melanie D.13

Affiliation:

1. Genentech South San Francisco California USA

2. Roche Welwyn UK

3. Astellas Pharma Global Development, Inc. Northbrook Illinois USA

4. Amgen Research Thousand Oaks California USA

5. Pfizer Groton Connecticut USA

6. Bristol Myers Squibb Lawrenceville New Jersey USA

7. Gilead Foster City California USA

8. Sunovion Marlborough Massachusetts USA

9. Novartis Basel Switzerland

10. Janssen R&D Spring House Pennsylvania USA

11. Blueprint Medicines Cambridge Massachusetts USA

12. ROME Therapeutics Cambridge Massachusetts USA

13. Merck & Co., Inc. Rahway New Jersey USA

14. Eli Lilly and Company Indianapolis Indiana USA

15. AbbVie North Chicago Illinois USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3